Wellcome Sanger Institute
The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.
|Telephone:||+44 (0)1223 834 244|
|Address:||Wellcome Genome Campus, Hinxton|
|Membership type:||Corporate 51+ (£1,000+VAT pa)|
Its success is founded on the expertise and knowledge of its people and the Institute seeks to share its discoveries and techniques with the next generation of genomics scientists and researchers worldwide.
The largest study of CRISPR action to date has developed a method to predict the exact mutations CRISPR-Cas9 gene editing can introduce to a cell.
29 November 2018Read in full
Cell map of healthy pregnancy could also help understand miscarriages or preeclampsia
14 November 2018Read in full
The largest genomic study of parasitic worms to date has identified hundreds of thousands of new genes and predicted many new potential drug targets and drugs.
8 November 2018Read in full
The genetic codes of 66,000 species in the UK are planned to be sequenced by the Wellcome Sanger Institute and its collaborators as part of a global effort to sequence the genomes of all 1.5 million known species of animals, plants, protozoa and fungi on Earth.
1 November 2018Read in full
By sequencing genes from over a quarter of a million cells across six mammalian species, researchers at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute and collaborators, have shown how genes in the immune response have varied activity between cells and species.
29 October 2018Read in full
Researchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involved in human cancer, the “Cancer Gene Census”.
25 October 2018Read in full
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists at the Wellcome Sanger Institute, MRC Cancer Unit, University of Cambridge and their collaborators uncovered a hidden world of mutations and evolution in our tissues as we age.
19 October 2018Read in full
Scientists have developed a successful method to make truly personalised predictions of future disease outcomes for patients with certain types of chronic blood cancers.
12 October 2018Read in full
Scientists at EMBL's European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute have discovered significant diversity in the genomes of 16 laboratory strains of mouse, potentially impacting future research in genetics, drug development and beyond.
9 October 2018Read in full
Business Development Associate
A newly-created post for an entry level Business Development Associate to join our Innovations team based at the world-famous We...
Location: Within 10 m of Cambridge
Salary: £40,000 - £50,000